Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1951 3
1952 3
1953 1
1955 1
1956 1
1957 2
1958 3
1959 2
1960 1
1961 2
1963 1
1966 1
1967 1
1970 2
1971 2
1972 1
1976 1
1980 2
1984 2
1985 2
1986 1
1989 4
1990 1
1991 4
1992 3
1993 3
1994 2
1995 2
1996 2
2000 2
2001 1
2002 2
2006 1
2007 4
2008 2
2009 3
2010 4
2011 3
2012 2
2013 5
2014 4
2015 7
2016 5
2017 6
2018 5
2019 4
2020 3
2021 5
2022 2
2023 1
2024 4
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.
McComb S, Arbabi-Ghahroudi M, Hay KA, Keller BA, Faulkes S, Rutherford M, Nguyen T, Shepherd A, Wu C, Marcil A, Aubry A, Hussack G, Pinto DM, Ryan S, Raphael S, van Faassen H, Zafer A, Zhu Q, Maclean S, Chattopadhyay A, Gurnani K, Gilbert R, Gadoury C, Iqbal U, Fatehi D, Jezierski A, Huang J, Pon RA, Sigrist M, Holt RA, Nelson BH, Atkins H, Kekre N, Yung E, Webb J, Nielsen JS, Weeratna RD. McComb S, et al. Among authors: raphael s. Mol Ther Oncol. 2024 Feb 13;32(1):200775. doi: 10.1016/j.omton.2024.200775. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596311 Free PMC article.
Broadly reactive anti-VHH antibodies for characterizing, blocking, or activating nanobody-based CAR-T cells.
McComb S, Dupont B, Shepherd A, Bennychen B, Marcil A, Tamblyn L, Raphael S, Sheff J, Hussack G, Moraitis AN, Wu C, Aubry A, Gadoury C, Lippens J, Pagé M, Fortin A, Joubert S, Lamoureux L, Parat M, Plante P, Malenfant F, Acchione M, Pohankova P, Schrag J, Acel A, Coutu M, Smith E, El Bakkouri M, Hill JJ, Tremblay TL, Manceur AP, Faulkes S, Webb J, Zafer A, Zhu Q, Nguyen T, Pon RA, Weeratna RD, Arbabi-Ghahroudi M. McComb S, et al. Among authors: raphael s. Antib Ther. 2025 Jun 27;8(3):242-258. doi: 10.1093/abt/tbaf011. eCollection 2025 Jul. Antib Ther. 2025. PMID: 40989106 Free PMC article.
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer.
Torlakovic EE, Baniak N, Barnes PJ, Chancey K, Chen L, Cheung C, Clairefond S, Cutz JC, Faragalla H, Gravel DH, Dakin Hache K, Iyengar P, Komel M, Kos Z, Lacroix-Triki M, Marolt MJ, Mrkonjic M, Mulligan AM, Nofech-Mozes S, Park PC, Plotkin A, Raphael S, Rees H, Seno HR, Thai DV, Troxell ML, Varma S, Wang G, Wang T, Wehrli B, Bigras G. Torlakovic EE, et al. Among authors: raphael s. Lab Invest. 2024 Jul;104(7):102076. doi: 10.1016/j.labinv.2024.102076. Epub 2024 May 9. Lab Invest. 2024. PMID: 38729353 Free article.
Functional oncocytic adrenocortical carcinoma.
Ali AE, Raphael SJ. Ali AE, et al. Among authors: raphael sj. Endocr Pathol. 2007 Fall;18(3):187-9. doi: 10.1007/s12022-007-9000-4. Endocr Pathol. 2007. PMID: 18058268 Review.
Special procedures.
RAPHAEL SI. RAPHAEL SI. R I Med J. 1951 Oct 31;34(10):531-3. R I Med J. 1951. PMID: 14892685 No abstract available.
131 results